This webinar by NPS MedicineWise (codesigned with the Australian Rheumatology Association and Arthritis Australia) reinforces the role of lowdose once weekly methotrexate as the cornerstone of treatment for rheumatoid arthritis. We address how important it is for all health professionals to deliver correct and consistent messaging to help dispel common myths and misconceptions that consumers have about methotrexate therapy for rheumatoid arthritis, thereby improving persistence and adherence.

CPD accreditation is available by viewing this webinar on the NPS MedicineWise elearning site https://www.nps.org.au/cpd/activities...

To download presentation slides, visit https://www.nps.org.au/webinar/ra